Newland Pharmaceutical Co., Ltd. (SHE:301277)
China · Delayed Price · Currency is CNY 8.65
-0.22 (-2.48%)
At close: Nov 13, 2026
Newland Pharmaceutical Revenue
Newland Pharmaceutical had revenue of 145.61M CNY in the quarter ending September 30, 2026, with 18.93% growth. This brings the company's total for the last twelve months to 733.72M, up 9.44% year-over-year. In the year 2025, Newland Pharmaceutical had annual revenue of 672.38M, down -7.44%. That makes Newland Pharmaceutical the 21,947th largest company in the world by revenue and 4,011th in China.
Revenue (ttm)
733.72M
Revenue Growth
+9.44%
P/S Ratio
4.62
Revenue / Employee
747.93K
Employees
981
Market Cap
3.39B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Newland Pharmaceutical breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 672.38M | -54.06M | -7.44% |
| Dec 31, 2024 | 726.44M | 75.00M | 11.51% |
| Dec 31, 2023 | 651.44M | 24.07M | 3.84% |
| Jan 1, 2023 | 627.36M | 113.53M | 22.09% |
| Jan 1, 2022 | 513.84M | 80.71M | 18.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.